NGeneBio Co., Ltd of Seoul at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

NGeneBio Co., Ltd

303-307, Daeryung Post Tower 1, 288 Digital-ro, Guro-gu, 08390 Seoul
Korea, Republic
Telephone +82 70 42246554
Fax +82 2 8669784

Hall map

MEDICA 2019 hall map (Hall 1): stand F61

Fairground map

MEDICA 2019 fairground map: Hall 1


Megan Kim

sales manager

Our products

Product category: DNA testing

NGS Breast Cancer kit, BRCAaccuTest™PLUS for BRCA1/2 mutation genes detection

BRCAaccuTestT™PLUS is a next-generation sequencing (NGS)-based in vitro diagnostic (IVD) product which detects mutations in BRCA1 /BRCA2 genes. BRCAaccuTest™ consists of NGS panel for detecting variants and clinical data analysis software (S/W). Rapid and precise detection of various mutations in BRCA 1/2 with NGS can be accomplished and the user-oriented analysis software enables convenient generation of clinical report. We have received CE-IVD and ISO 13485 in 2017.

More Less

Product category: DNA testing

NGS Solid Cancer kit, SOLIDaccuTest™ for Lung | Gastric | Colon | Breast and Ovarian Cancer & Melanoma, etc.

SOLIDaccuTestTM is designed to explorer genetic variants associated with solid tumors using NGS technology. It reflected the latest research trends and is optimized for the medical purpose by selecting essential genes for solid cancer diagnosis.

More Less

Product category: DNA testing

NGS Hematological Malignancies kit, HEMEaccuTest™ for Acute Myeloid Leukemia (AML) | Acute Lymphoid Leukemia (ALL) | Multiple Myeloma (MM) Myelodysplastic/Myeloproliferative Neoplasm (MDS/MPN) | Lymphoma

Hematologic malignancy refers to malignant tumors that occur in blood, blood vessels, lymph nodes, lymphatic organs, and constitute a variety of gene instability such as gene mutation, rearrangement, and amplification.
While existing gene analysis technology only confirms the presence of certain mutations in cancer genes, diagnosis using NGS technology makes it possible to analyze the major gene mutation patterns of patients and identify the side-by-side variations to enable personalized diagnosis. HEMEaccuTest™ is a product for detecting and analyzing mutations in blood cancer-related genes using NGS. we have received CE-IVD in 2018. 

More Less

Product category: DNA testing

NGS HLA typing kit, HLAaccuTest

-New Launched Product (CE-IVD planned in 4Q/2019)
-Complete workflow for NGS HLA typing: NGS panel kit (HLAaccuTestTM) & analysis SW (EasyHLAanalyzerTM) – TAT 3 days
-Comprehensive primer coverage for 11 HLA loci, matching IMGT/HLA DB
-Automatic NGS data analysis and individual allele assignments
-Easy-to-use, user-friendly UI and intuitive operation

More Less

Product category: DNA testing

NGS Analysis Software, NGeneAnalySys™

NGeneAnalySys™ is a software for analysis of the genetic testing data produced by next-generation sequencing (NGS) and helps to report in clinical-grade for oncology test.

It provides accurate pathogenic variants information based on ACMG guideline and relevant therapy information based on databases (solid tumor / hematologic malignancies), which enables efficient on-site data analysis for clinical NGS.

More Less

Product category: DNA testing

DNA profiling kit, IDaccuTest™ for Paternity test | Forensic DNA analysis | Chimerism test

-STR Technology:
DNA regions with short repeat units (usually 2-7 bp in length) are called Short Tandem Repeats (STR). STRs are found surrounding the chromosomal centromere (the structural center of the chromosomes). STRs have proven to have several benefits that make them especially suitable for human identification. STRs have become well-known DNA markers for genetic profiling since they are easily amplified by polymerase chain reaction (PCR); the PCR products of STRs are generally consisteet in amount, making analysis easier. The smaller size of STR alleles is suitable for use in forensic applications, since DNA degradation in common in forensic samples, interfering PCR amplifications. The small target amplificaiton of STR and overcome the difficulty in forensic DNA samples.

-Product list
Autosomal STR (A-STR) - IDaccuTest A-STR 16plex, IDaccuTest A-STR 9plex
Chromosome STR (Y-STR) - IDaccuTest Y-STR 

More Less

About us

Company details

Welcome to NGeneBio

NGeneBio was founded in October 2015 as a joint venture between Genecurix and Korea Telecom, develops in vitro diagnostics (IVD) / companion diagnostics (CDx) products and bioinformatics software (S/W) with cutting-of-edge technologies including next generation sequencing (NGS). The company launched NGS-based hereditary breast / ovarian cancer panel (BRCAaccuTestTM) with clinical analysis S/W (NGeneAnalysisTM) and received CE-IVD mark in Jun/2017.

NGS panels for solid tumor/hematologic malignancies and BRCA PARP inhibitor CDx test will be launched, inclusive of clinical data analysis SW platform. In support of laboratory medicine community, our mission is to provide clinically validated NGS-IVD / CDx products/services with convergence of innovative biotechnology and bioinformatics.

We have been working on research and development with the cooperation of the anticancer diagnosis project team, domestic and foreign hospitals and biotech companies. We have been striving to secure the technology and develop business model of mid- to long-term perspectives through external patent license-in in addition to the company’s own patent discovery.

We are doing our utmost to achieve our goal of global healthcare service provider based on four core values of challenging execution, respect for life, human resource development and customer trust, and we look forward to your continued support and interest.

More Less